###### Significance of this study

What is already known about this subject?
=========================================

-   The triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio, visceral adiposity index (VAI), lipid accumulation product (LAP) and triglycerides × fasting glucose (TyG) index have been developed as surrogate measures of insulin resistance based on anthropometric and/or biochemical parameters routinely collected in clinical practice.

What are the new findings?
==========================

-   Among the four surrogate indexes of insulin resistance, LAP index correlates better with insulin sensitivity assessed by the gold standard euglycemic hyperinsulinemic clamp technique.

-   LAP index was the only surrogate index showing significant association with the insulin sensitivity in individuals with impaired glucose tolerance or type 2 diabetes.

-   The ability of LAP index to identify subjects with insulin resistance is higher than TG/HDL-C ratio, VAI and TyG indexes.

-   All the four indexes have a similar ability to detect individuals with subclinical atherosclerosis. Conversely, LAP index had the greatest ability to recognize individuals with increased vascular stiffness.

How might these results change the focus of research or clinical practice?
==========================================================================

-   Among the four surrogate measures of insulin resistance based on anthropometric and biochemical parameters, LAP index is the best discriminator of insulin resistance and subclinical vascular damage.

-   Assessment of LAP index in clinical practice should be preferred to TG/HDL-C ratio, VAI and TyG indexes for a better cardiometabolic risk stratification.

Introduction {#s1}
============

Insulin resistance is a characteristic trait of both pre-diabetes[@R1] and metabolic syndrome.[@R4] Insulin resistance is considered central to the pathophysiology of type 2 diabetes,[@R7] and predicts the development of cardiovascular disease.[@R9] Although insulin resistance is an important determinant of cardiometabolic diseases, a direct measure of insulin sensitivity by the gold standard euglycemic hyperinsulinemic clamp technique[@R12] is impractical for large-scale epidemiological studies, due to the laborious, expensive, and time-consuming procedure required. Therefore, many surrogate indexes of insulin sensitivity have been proposed using anthropometric variables, fasting insulin and/or glucose levels or insulin and glucose levels during an oral glucose tolerance test (OGTT).[@R13] An ideal surrogate index of insulin sensitivity for use in large epidemiological studies should be based on affordable anthropometric and/or laboratory measures routinely gathered in clinical settings. Among these, the visceral adiposity index (VAI),[@R16] and the lipid accumulation product (LAP), both based on anthropometric and laboratory parameters[@R17] have been developed and analyzed in relation to homeostatic model assessment of insulin resistance (HOMA-IR), but not to the gold standard measure of insulin sensitivity assessed by the euglycemic hyperinsulinemic clamp method.[@R18] Additionally, two other surrogate indexes of insulin sensitivity based on plasma triglyceride (TG) and high-density lipoprotein cholesterol (HDL-C) measurements, that is, the triglycerides × fasting glucose (TyG) index and TG/HDL-C concentration ratio, have been suggested as surrogate estimates of insulin sensitivity, and validated in comparison to the euglycemic hyperinsulinemic clamp method,[@R26] the steady-state plasma glucose (SSPG) concentration during the insulin suppression test[@R27] or a 3-hour hyperglycemic clamp test.[@R28] Although these two lipid-based surrogate indexes have been studied in non-diabetic individuals, in subjects with impaired fasting glucose (IFG), and in patients with type 2 diabetes,[@R26] it is unknown whether they might be useful in the identification of insulin resistance in individuals with impaired glucose tolerance (IGT). In the present study, we pursued two aims: (1) to compare VAI, LAP, TyG, and TG/HDL-C ratio surrogate indexes with the euglycemic hyperinsulinemic clamp method, the gold standard measure of insulin sensitivity, in a large cohort of European individuals with different degrees of glucose tolerance, and (2) to examine the relationship of surrogate measures of insulin sensitivity with classical and inflammatory cardiovascular risk factors, as well as carotid intima-media thickness (IMT), a reliable index of subclinical atherosclerosis[@R29] related to insulin resistance.[@R30]

Methods {#s2}
=======

Study subjects {#s2-1}
--------------

The study sample includes 631 adults (age \>18 years) consecutively recruited at the Department of Systems Medicine, University of Tor Vergata, Rome, and at the Department of Medical and Surgical Sciences of the University 'Magna Graecia' of Catanzaro, Italy, according to a previously described protocol.[@R3] On the first day, after an overnight fasting, all subjects underwent anthropometrical evaluation including measurements of body mass index (BMI), waist circumference, and body composition evaluated by bioelectrical impedance. Height was measured to the nearest 0.1 cm, while body weight was measured with a calibrated electronic scale to the nearest 0.1 kg. Waist circumference was measured at the umbilical level, at the midpoint between the iliac crest and the rib cage. The BMI was calculated as body weight in kilograms divided by height in square meters (kg/m^2^). Blood pressure was measured after a 5 min rest at the right upper arm, in the sitting position, with a sphygmomanometer for three times and the mean was used in the analyses. Pulse pressure was calculated as the difference between systolic blood pressure and diastolic blood pressure. A value of pulse pressure ≥60 mm Hg was used as index of increased vascular stiffness.[@R32] A 75 g OGTT was performed with basal and 2-hour postload sampling for plasma glucose assays. On the second day, after a 12-hour fasting, participants underwent a euglycemic hyperinsulinemic clamp study, as previously described.[@R33] Briefly, a priming dose of insulin was administrated during the early 10 min to acutely increase plasma insulin followed by continuous insulin infusion fixed at 40 mU/m^2^ × min. Blood glucose levels were maintained constant during the 2-hour clamp study by infusing 20% glucose at varying rates according to blood glucose measurements assessed by a glucose analyzer at 5 min intervals. Glucose metabolized by the whole body (M) was calculated as the mean rate of glucose infusion measured during the last 60 min of the clamp examination (steady state) and was expressed as milligrams per minute per kilogram fat-free mass (M~FFM~). Subjects were considered insulin resistant when they were in the lower quartile of M~FFM~ values of the study cohort.

Carotid IMT was measured by ATL HDI 3000 ultrasound system (Advanced Technology Laboratories, Bothell, WA) equipped with a 5 MHz linear array transducer as previously described.[@R34] For each patient two measurements were performed bilaterally, and the values were averaged, to obtain the mean of IMT of the common carotid artery. Ultrasound examinations were performed by a skilled examiner who was unaware of clinical and laboratory findings of participants. A value of IMT\>0.9 mm was used as index of vascular atherosclerosis.[@R32]

According to the American Diabetes Association (ADA) criteria,[@R35] individuals were classified as having normal glucose tolerance (NGT) when fasting glucose levels were \<100 mg/dL (5.5 mmol/L) and 2-hour postload \<140 mg/dL (\<7.77 mmol/L), isolated IFG when fasting glucose levels were 100--125 mg/dL (5.5--6.9 mmol/L) and 2-hour postload \<140 mg/dL (\<7.77 mmol/L), IGT when fasting glucose levels were \<126 mg/dL (\<7 mmol/L) and 2-hour postload was 140--199 mg/dL (7.77--11.0 mmol/L), and newly diagnosed type 2 diabetes when fasting glucose levels were ≥126 mg/dL (≥7 mmol/L) or 2-hour postload was ≥200 mg/dL (≥11.1 mmol/L).

Analytical determinations {#s2-2}
-------------------------

Glucose, TGs, total cholesterol and HDL-C concentrations were determined by enzymatic methods (Roche, Basel, Switzerland). High-sensitivity C-reactive protein (hsCRP) levels were measured by automated instrument BN II System analyzer (Siemens Healthcare, Marburg, Germany) with the CardioPhase hsCRP kit. Uric acid concentrations were determined by the uricase/peroxidase method implemented in an autoanalyzer (Boehringer Mannheim, Mannheim, Germany). Plasma insulin concentrations were measured by a chemiluminescence-based assay (Immulite, Siemens, Italy).

Definition of LAP, VAI, TyG, and TG/HDL-C ratio surrogate indexes {#s2-3}
-----------------------------------------------------------------

The LAP index was calculated as (waist circumference -- 65) × (TGs \[mmol/L\]) in men, and (waist circumference − 58) × (TG \[mmol/L\]) in women.[@R17] The VAI was index calculated using gender-specific formulas: men (waist circumference / 39.68 + \[1.88×BMI\]) × (TGs / 1.03) × (1.31/HDL-C); women: (waist circumference / 36.58 + \[1.89×BMI\]) × (TGs / 0.81) × (1.52/HDL-C), where both TG and HDL-C levels are expressed in mmol/L.[@R16] The TyG index was calculated as the Ln\[fasting TGs (mg/dL) × fasting glucose (mg/dL)/2\].[@R26] The TG/HDL-C ratio was calculated as the ratio of TG (mg/dL) to HDL-C (mg/dL).[@R27]

Statistical analysis {#s2-4}
--------------------

TG/HDL-C ratio, LAP and VAI indexes, hsCRP, and TG values were natural log transformed for statistical analysis due to their skewed distribution. Continuous data are expressed as means±SD. A general linear model with adjustment for age and gender was used to compare anthropometric and metabolic differences between the groups. Categorical variables were compared by χ^2^ test. Relationships between variables were determined by Pearson's correlation coefficient (r). As a measure of discrimination, the ability of each index to detect subjects with insulin resistance, defined as the lower quartile of M~FFM~ values, vascular atherosclerosis, defined as IMT\>0.9 mm, and increased vascular stiffness, defined as a pulse pressure ≥60 mm Hg,[@R32] was assessed by the area under the receiver operating characteristic (ROC) curve. The area under the ROC curve (AUC) was used as a measure of how well surrogate indexes of insulin sensitivity identify insulin-resistant individuals, vascular damage or increased vascular stiffness. An AUC of 1.0 points to perfect classification of individuals with insulin resistance or organ damage, whereas 0.5 means that the classification is not better than chance. Statistical differences between the AUCs were determined by the method described by DeLong *et al*.[@R36] Youden index was used to derive the optimal threshold of each marker to detect insulin resistance, vascular damage, and increased vascular stiffness. All tests were two sided, and a p value \<0.05 was considered statistically significant. All calculations were performed with SPSS V.22.0 software program for Windows.

Results {#s3}
=======

A total of 631 individuals (350 women and 281 men) were enrolled, including 446 subjects with NGT, 60 subjects with IFG, 95 subjects with IGT, and 30 individuals with newly diagnosed type 2 diabetes. In the whole study sample, the mean age was 39.6±10.7 years, BMI was 30.0±7.1 kg/m^2^, and the proportion of participants with family history of type 2 diabetes was 75%. Anthropometric and biochemical features of the study participants grouped on the basis of glucose tolerance are shown in [table 1](#T1){ref-type="table"}. Deterioration of glucose homeostasis from NGT to type 2 diabetes was associated with age and several measures of adiposity, cardiometabolic and subclinical atherosclerosis including BMI, visceral adiposity, systolic blood pressure, pulse pressure, HDL, TGs, fasting and 2-hour postload glucose, uric acid, hsCRP, and IMT. As expected, deterioration of glucose homeostasis was associated with a graded decline in insulin sensitivity directly measured as insulin-stimulated glucose disposal (M~FFM~) by euglycemic hyperinsulinemic clamp study, and a graded increase in the values of the surrogate indexes of insulin resistance LAP, VAI, TyG, and TG/HDL-C concentration ratio ([table 1](#T1){ref-type="table"}).

###### 

Clinical characteristics of study population subdivided according to glucose tolerance status

                                                               Whole sample   NGT         IFG         IGT         Type 2 diabetes   P value
  ------------------------------------------------------------ -------------- ----------- ----------- ----------- ----------------- ------------
  Gender (male/female)                                         281/350        179/267     41/19       42/53       19/11             \<0.0001
  Age (years)                                                  39.6±10.7      37.4±10.0   43.4±10.1   44.3±10.4   50.6±10.3         \<0.0001
  BMI (kg/m^2^)                                                30.0±7.1       29.3±7.2    29.8±5.8    33.2±6.6    31.7±7.4          \<0.0001\*
  Waist circumference (cm)                                     97±15          94±15       97±13       104±13      106±17            \<0.0001\*
  Systolic blood pressure (mm Hg)                              126±16         123±16      132±14      133±17      138±17            0.004
  Diastolic blood pressure (mm Hg)                             80±11          79±11       83±9        83±11       88±11             0.14
  Pulse pressure (mm Hg)                                       45±10          44±10       48±9        50±10       50±10             0.01
  Total cholesterol (mg/dL)                                    196±39         193±38      202±34      207±41      200±42            0.21
  HDL (mg/dL)                                                  51±14          53±14       49±11       48±13       41±10             \<0.0001
  Triglycerides (mg/dL)                                        124±84         109±62      131±92      158±96      212±176           \<0.0001
  Fasting glucose (mg/dL)                                      92±16          86±7        105±4       95±12       137±42            \<0.0001
  2-hour glucose (mg/dL)                                       116±33         104±19      106±19      160±15      211±40            \<0.0001
  Uric acid (mg/dL)                                            4.9±1.3        4.7±1.4     5.1±1.2     5.4±1.1     5.2±1.4           \<0.0001
  hsCRP (mg/L)                                                 2.6±2.6        2.4±2.4     2.1±2.9     3.5±2.8     3.0±1.7           0.003
  Intima-media thickness (mm)                                  0.71±0.15      0.69±0.15   0.75±0.14   0.73±0.14   0.87±0.15         0.002
  Insulin-stimulated glucose disposal (mg/min × kg FFM)        8.7±4.3        9.5±4.4     8.9±3.9     6.5±3.4     5.4±2.8           \<0.0001
  Steady-state plasma insulin levels during the clamp (mU/L)   86±33          84±33       92±32       93±33       78±24             0.094
  Triglyceride/HDL-C ratio                                     2.81±2.65      2.37±1.89   3.08±3.1    3.63±2.86   6.15±5.93         \<0.0001
  LAP index                                                    53.8±48.8      45.2±38.1   49.5±32.1   79.6±59.1   109.5±97.7        \<0.0001
  VAI                                                          1.93±1.83      1.63±1.20   1.93±1.82   2.59±2.08   4.28±4.61         \<0.0001
  TyG index                                                    9.17±0.59      9.03±0.51   9.37±0.53   9.48±0.53   10.1±0.73         \<0.0001

Data are means±SD. Triglyceride/HDL-C concentration ratio, LAP, VAI indexes, hsCRP, and triglyceride values were log transformed for statistical analysis, but values in the table represent back transformation to the original scale. Categorical variables were compared by χ^2^ test. Comparisons between the study groups were performed using a general linear model. P values refer to results after analyses with adjustment for age and gender.

\*P values refer to results after analyses with adjustment for gender.

BMI, body mass index; FFM, fat-free mass; HDL, high-density lipoprotein; HDL-C, high-density lipoprotein cholesterol; hsCRP, high-sensitivity C-reactive protein; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; LAP, lipid accumulation product; NGT, normal glucose tolerance; TyG, triglycerides × fasting glucose; VAI, visceral adiposity index.

Correlations of surrogate indexes of insulin resistance with insulin sensitivity assessed by euglycemic hyperinsulinemic clamp study {#s3-1}
------------------------------------------------------------------------------------------------------------------------------------

[Table 2](#T2){ref-type="table"} shows the Pearson's correlation coefficient between surrogate indexes of insulin resistance with insulin sensitivity directly assessed by euglycemic hyperinsulinemic clamp. All the four indexes showed a significant correlation with insulin-stimulated glucose disposal (M~FFM~) in the whole study group. However, when the relationships were examined across glucose tolerance groups the correlations remained statistically significant in subjects with NGT and IFG, but not among those with IGT or type 2 diabetes with the exception of LAP index ([table 2](#T2){ref-type="table"}). Indeed, the LAP index exhibited the stronger correlation with insulin-stimulated glucose disposal (M~FFM~) than did the other indexes across glucose tolerance groups. A significant difference in correlation coefficients using the Steiger's Z test was observed by comparing LAP index and VAI (p=0.04) or TyG (p=0.03), but not in comparison with TG/HDL-C ratio (p=0.10).

###### 

Pearson's correlation coefficient relating surrogate indexes of insulin resistance to insulin-stimulated glucose disposal (M~FFM~) across glucose tolerance categories

  ----------------------------------------------------------------------------------------------------------------------------------------------
                             Whole sample\   P value    NGT\      P value    IFG\     P value    IGT\     P value   Type 2 diabetes\   P value
                             (n=631)                    (n=446)              (n=60)              (n=95)             (n=30)             
  -------------------------- --------------- ---------- --------- ---------- -------- ---------- -------- --------- ------------------ ---------
  Triglyceride/HDL-C ratio   −0.411          \<0.0001   −0.407    \<0.0001   −0.292   0.01       −0.109   0.14      −0.314             0.09

  LAP index                  −0.469          \<0.0001   −0.442    \<0.0001   −0.488   \<0.0001   −0.252   0.007     −0.472             0.008

  VAI                        −0.392          \<0.0001   −0.372    \<0.0001   −0.316   0.007      −0.129   0.10      −0.327             0.07

  TyG index                  −0.385          \<0.0001   −0.374    \<0.0001   −0.268   0.01       −0.028   0.39      −0.332             0.07
  ----------------------------------------------------------------------------------------------------------------------------------------------

HDL-C, high-density lipoprotein cholesterol; IFG, impaired fasting glucose; IGT, impaired glucose tolerance; LAP, lipid accumulation product; NGT, normal glucose tolerance; TyG, triglycerides × fasting glucose; VAI, visceral adiposity index.

As a measure of discrimination, the ability of surrogate indexes to detect individuals with insulin resistance defined as the bottom quartile of M~FFM~ values was assessed by the AUC. As shown in [table 3](#T3){ref-type="table"}, and [online supplementary figure 1](#SP1 SP2){ref-type="supplementary-material"}, LAP index had the highest AUC followed by TG/HDL-C ratio, TyG index and VAI in the whole study group.

###### 

Discriminatory accuracy and cut-off values for triglyceride/HDL-C ratio, LAP, VAI, and TyG index in identifying subjects with insulin resistance defined as the bottom quartile of M~FFM~ values

                             Sensitivity   Specificity   Positive predictive value   Negative predictive value   AUC (95% CI)             P value*\**   Diagnostic likelihood ratio (+)   Youden index   Cut-off
  -------------------------- ------------- ------------- --------------------------- --------------------------- ------------------------ ------------- --------------------------------- -------------- ---------
  Triglyceride/HDL-C ratio   0.82          0.48          0.35                        0.89                        0.693 (0.646 to 0.729)   0.01          1.60                              0.309          0.57
  LAP index                  0.70          0.65          0.40                        0.86                        0.728 (0.692 to 0.762)   NA            2.00                              0.350          3.84
  VAI                        0.73          0.54          0.35                        0.86                        0.688 (0.650 to 0.724)   0.002         1.61                              0.276          0.34
  TyG index                  0.59          0.70          0.40                        0.84                        0.688 (0.650 to 0.723)   0.005         2.04                              0.305          9.36

\*P value of receiver operating characteristic (ROC) test between each marker and benchmark LAP index, respectively.

AUC, area under the ROC curve; HDL-C, high-density lipoprotein cholesterol; LAP, lipid accumulation product; NA, not applicable; TyG, triglycerides × fasting glucose; VAI, visceral adiposity index.

Correlations of surrogate indexes of insulin resistance with cardiometabolic risk factors and subclinical vascular damage and stiffness {#s3-2}
---------------------------------------------------------------------------------------------------------------------------------------

[Table 4](#T4){ref-type="table"} shows the Pearson's correlation coefficient between surrogate indexes of insulin resistance with cardiometabolic risk factors and indicators of vascular damage including pulse pressure and IMT. All the four indexes showed a highly significant correlation with systolic and diastolic blood pressure, pulse pressure, uric acid levels, hsCRP, and IMT.

###### 

Pearson's correlation coefficient relating surrogate indexes of insulin resistance to cardiometabolic risk factors and subclinical vascular damage

                                     Triglyceride/HDL-C ratio   P value    LAP index   P value    VAI     P value    TyG index   P value
  ---------------------------------- -------------------------- ---------- ----------- ---------- ------- ---------- ----------- ----------
  Systolic blood pressure (mm Hg)    0.296                      \<0.0001   0.421       \<0.0001   0.268   \<0.0001   0.358       \<0.0001
  Diastolic blood pressure (mm Hg)   0.293                      \<0.0001   0.406       \<0.0001   0.260   \<0.0001   0.338       \<0.0001
  Pulse pressure (mm Hg)             0.152                      \<0.0001   0.229       \<0.0001   0.145   \<0.0001   0.203       \<0.0001
  Uric acid (mg/dL)                  0.437                      \<0.0001   0.449       \<0.0001   0.346   \<0.0001   0.383       \<0.0001
  hsCRP (mg/L)                       0.267                      \<0.0001   0.443       \<0.0001   0.314   \<0.0001   0.234       \<0.0001
  Intima-media thickness (mm)        0.233                      \<0.0001   0.247       \<0.0001   0.212   \<0.0001   0.276       \<0.0001

HDL-C, high-density lipoprotein cholesterol; hsCRP, high-sensitivity C-reactive protein; LAP, lipid accumulation product; TyG, triglycerides × fasting glucose; VAI, visceral adiposity index.

We evaluated the ability of surrogate indexes of insulin resistance to detect individuals with atherosclerosis, defined as IMT\>0.9 mm, and increased vascular stiffness, defined as pulse pressure ≥60 mm Hg. As shown in [table 5](#T5){ref-type="table"}, and [online supplementary figures 2 and 3](#SP1 SP3 SP4){ref-type="supplementary-material"}, no differences were observed in the ability of the four surrogate indexes in detecting individuals with atherosclerosis as indicated by similar values of AUCs. By contrast, LAP index had the greatest ability to detect individuals with increased vascular stiffness as assessed by the higher value of the AUC ([table 5](#T5){ref-type="table"}).

###### 

Discriminatory accuracy and cut-off values for triglyceride/HDL-C ratio, LAP, VAI, and TyG index in identifying individuals with subclinical vascular damage

                                                                              Sensitivity   Specificity   Positive predictive value   Negative predictive value   AUC (95% CI)             P value*\**   Diagnostic likelihood ratio (+)   Youden index   Cut-off
  --------------------------------------------------------------------------- ------------- ------------- --------------------------- --------------------------- ------------------------ ------------- --------------------------------- -------------- ---------
  **Vascular atherosclerosis defined as IMT\>0.9 mm**                                                                                                                                                                                                     
  Triglyceride/HDL-C ratio                                                    0.950         0.412         0.134                       0.989                       0.701 (0.656 to 0.742)   0.15          1.62                              0.362          0.499
  LAP index                                                                   0.900         0.494         0.146                       0.981                       0.742 (0.699 to 0.782)   NA            1.78                              0.394          3.623
  VAI                                                                         0.750         0.601         0.153                       0.962                       0.705 (0.661 to 0.747)   0.12          1.88                              0.351          0.484
  TyG index                                                                   0.825         0.592         0.163                       0.972                       0.739 (0.696 to 0.779)   0.91          2.02                              0.417          9.192
  **Increased vascular stiffness defined as pulse pressure \>60** **mm Hg**                                                                                                                                                                               
  Triglyceride/HDL-C ratio                                                    0.662         0.473         0.169                       0.897                       0.551 (0.510 to 0.590)   0.001         1.26                              0.136          0.659
  LAP index                                                                   0.721         0.500         0.189                       0.917                       0.614 (0.574 to 0.652)   NA            1.44                              0.221          3.664
  VAI                                                                         0.744         0.415         0.171                       0.909                       0.562 (0.522 to 0.602)   0.001         1.27                              0.276          0.177
  TyG index                                                                   0.744         0.417         0.171                       0.910                       0.579 (0.539 to 0.618)   0.04          1.28                              0.161          8.987

\*P value of receiver operating characteristic (ROC) test between each marker and benchmark LAP index, respectively.

AUC, area under the ROC curve; HDL-C, high-density lipoprotein cholesterol; IMT, intima-media thickness; LAP, lipid accumulation product; NA, not applicable; TyG, triglycerides × fasting glucose; VAI, visceral adiposity index.

Discussion {#s4}
==========

Compelling evidence suggests that insulin resistance, defined as decreased sensitivity of target organs to the metabolic actions of insulin, is a pathophysiological feature of the metabolic syndrome, and pre-diabetes, and heralds both type 2 diabetes and cardiovascular disease.[@R1] The gold standard method for assessing insulin sensitivity is the euglycemic hyperinsulinemic clamp technique.[@R12] Nonetheless, the glucose clamp method is technically demanding, invasive, costly, and time consuming, thus impeding its application in large epidemiological studies. Therefore, surrogate indexes based on inexpensive anthropometric and/or laboratory parameters collected in routine clinical practice have been developed to quantify insulin sensitivity.[@R13] Given the extensive use of surrogate indexes of insulin sensitivity in epidemiological studies, it is important to compare their relationships with insulin sensitivity assessed by the euglycemic hyperinsulinemic clamp, and establish which surrogate index is the most predictive of insulin resistance. To address this issue, we compare four surrogate indexes based on anthropometric and/or laboratory parameters, that is, TG/HDL-C ratio, VAI, LAP and TyG index, with insulin sensitivity directly measured by the euglycemic hyperinsulinemic clamp method in 631 individuals having different degrees of glucose tolerance. We found that worsening of glycemic homeostasis from NGT status to type 2 diabetes was associated with a graded increase in the values of the four surrogate indexes of insulin resistance. However, LAP index was a better correlate of insulin sensitivity than VAI, TyG, and TG/HDL-C ratio indexes, and was the only index showing significant association with the insulin sensitivity in individuals with IGT or type 2 diabetes. Accordingly, based on the ROC analysis, LAP was the best index in discriminating individuals with insulin resistance because it was the only measure with an AUC value higher than the reference threshold of 0.7, suggesting that LAP index offers more clinical information than that achieved by using VAI, TyG, and TG/HDL-C ratio indexes. To the best of our knowledge, this is the first systematic study that simultaneously compared VAI, LAP, TyG, and TG/HDL-C ratio indexes with the euglycemic hyperinsulinemic clamp method in a large data set to determine which index is most reliable. Indeed, previous studies have examined the relationship between these four indexes and insulin resistance[@R18]; however, these studies differ from the present analysis for some important aspects. First, in most studies,[@R18] insulin resistance was assessed by the HOMA-IR index, which is another surrogate index of insulin resistance derived from fasting glucose and insulin levels, and is thought to primarily reflect hepatic insulin resistance. By contrast, the euglycemic hyperinsulinemic clamp method was performed under steady-state insulin levels capable to suppress hepatic glucose production allowing direct assessment of glucose disposal predominantly into skeletal muscle. Second, a few studies have addressed the relative values of multiple insulin sensitivity indexes in the same study group.[@R18] Additionally, in the three studies that have compared the TyG, and TG/HDL-C ratio indexes with direct measure of insulin sensitivity by the euglycemic hyperinsulinemic clamp method,[@R26] the SSPG concentration during the insulin suppression test[@R27] or a 3-hour hyperglycemic clamp test,[@R28] the authors analyzed the relationships between the surrogate indexes with insulin sensitivity directly assessed in the whole group including indistinctly individuals with NGT, IFG and type 2 diabetes, thus lacking to determine whether the surrogate indexes are equally good correlates in individuals with different conditions of glucose tolerance. This difference is clinically meaningful since we have observed that among the examined indexes, only LAP index exhibited a significant association with insulin sensitivity in individuals with IGT or type 2 diabetes.

All the four indexes are highly significantly associated with cardiovascular risk factors, and subclinical vascular damage measured as IMT. The strength by which the four surrogate indexes correlate with cardiovascular risk factors was similar. Moreover, based on the ROC analysis, LAP, VAI, TyG, and TG/HDL-C ratio indexes are equally fair discriminators of vascular atherosclerosis defined as IMT\>0.9 mm because all of them pass the reference threshold of 0.7. By contrast, the ROC analysis indicates that the four indexes are poor discriminators of increased vascular stiffness defined as pulse pressure \>60 mm Hg as none of them showed an AUC value higher than 0.7 ([table 5](#T5){ref-type="table"}).

The present study has some strengths. The main strength is that surrogate indexes were evaluated versus the euglycemic hyperinsulinemic clamp gold standard test in a large sample of subjects of both genders with various degrees of glucose tolerance. All tests including anthropometric measures, OGTT, and euglycemic hyperinsulinemic clamp studies were collected at the same time by a trained staff after a standardized training. Nonetheless, the current study has some limitations that should be considered. First, glucose tolerance by OGTT was only measured once. According to the ADA recommendations,[@R35] one positive test is not sufficient to establish the degree of glucose tolerance, which should be defined on the basis of at least two separate measurements, and therefore, some participants might have been misclassified. Second, endogenous glucose production during clamp studies has not been directly assessed by tracer methods, therefore we cannot firmly exclude that a residual hepatic glucose production occurs in some participants. Furthermore, the study was carried on a European population, and needs to be replicated in other ethnic groups before its widespread applicability. Additionally, the cross-sectional design of the study lacking prospective data impedes any assumption about cause and temporal relationships. Additionally, arterial stiffness was not directly assessed by measuring pulse wave velocity, but pulse pressure was used as proxy of arterial stiffness. And finally, residual confounding by unmeasured factors cannot be excluded.

In conclusion, the findings of the present study suggest that LAP index is a more reliable discriminator of insulin resistance in clinical settings as compared with VAI, TyG, and TG/HDL-C ratio indexes. The better ability of LAP index to identify individuals with insulin resistance compared with the other surrogate measures may, of clinical relevance, be due to the fact that it is based on inexpensive measurements of waist circumference and TGs easily available in clinical practice, which are also accessible in high-risk groups of undeveloped countries for estimating insulin resistance.
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